Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses
Katherine J. Brempelis(Seattle Children's Hospital), Courtney A. Crane(APT Therapeutics (United States))
Cited by 81
Related Papers
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
|Journal of Clinical Oncology|2017|345
Isolation of Non-parenchymal Cells from the Mouse Liver
|Methods in molecular biology|2015|64